ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation
- PMID: 37428488
- PMCID: PMC10528287
- DOI: 10.1021/acs.jpcb.3c01787
ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation
Abstract
Chronic inflammation contributes to several diseases, but its resolution is driven by specialized pro-resolving mediators (SPM) such as resolvin D1 (RvD1) and its epimer aspirin-triggered resolvin D1 (AT-RvD1), both biosynthesized from ω-3 fatty docosahexaenoic acid (DHA). RvD1 and AT-RvD1 have anti-inflammatory and pro-resolution potentials, and their effects could be mediated by formyl peptide receptor type 2 receptor ALX/FPR2, a G-protein-coupled receptor (GPCR). In this work, we performed 44 μs of molecular dynamics simulations with two complexes: FPR2@AT-RvD1 and FPR2@RvD1. Our results show the following: (i) in the AT-RvD1 simulations, the ALX/FPR2 receptor remained in the active state in 62% of the frames, while in the RVD1 simulations, the receptor remained in the active state in 74% of the frames; (ii) two residues, R201 and R205, of ALX/FPR2 appear, establishing interactions with both resolvins in all simulations (22 in total); (iii) RvD1 hydrogen bonds with R201 and R205 presented higher frequency than AT-RvD1; and (iv) residues R201 and R205 are the two receptor hotspots, demonstrated by the binding free calculations. Such results show that the ALX/FPR2 receptor remained in the active state for longer in the FPR2@RvD1 simulations than in the FPR2@AT-RvD1 simulations.
Conflict of interest statement
Disclosure statement
No potential conflict of interest was reported by the authors.
Figures





Similar articles
-
Insights into the Activation Mechanism of the ALX/FPR2 Receptor.J Phys Chem Lett. 2020 Nov 5;11(21):8952-8957. doi: 10.1021/acs.jpclett.0c02052. Epub 2020 Oct 8. J Phys Chem Lett. 2020. PMID: 33030905
-
Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.Am J Pathol. 2012 May;180(5):2018-27. doi: 10.1016/j.ajpath.2012.01.028. Epub 2012 Mar 23. Am J Pathol. 2012. PMID: 22449948 Free PMC article.
-
Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury.J Neuroinflammation. 2020 Aug 14;17(1):239. doi: 10.1186/s12974-020-01918-x. J Neuroinflammation. 2020. PMID: 32795323 Free PMC article.
-
Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways.Pharmacol Ther. 2013 Dec;140(3):280-9. doi: 10.1016/j.pharmthera.2013.07.007. Epub 2013 Jul 21. Pharmacol Ther. 2013. PMID: 23880288 Review.
-
Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential.Eur J Med Chem. 2021 Mar 5;213:113167. doi: 10.1016/j.ejmech.2021.113167. Epub 2021 Jan 12. Eur J Med Chem. 2021. PMID: 33486199 Review.
Cited by
-
Proresolving Lipid Mediators in the Respiratory System.Annu Rev Physiol. 2025 Feb;87(1):491-512. doi: 10.1146/annurev-physiol-020924-033209. Epub 2025 Feb 3. Annu Rev Physiol. 2025. PMID: 39303274 Free PMC article. Review.
-
ALX/FPR2 Receptor Activation by Inflammatory (fMLFII) and Pro-resolving (LXA4 and RvD3) Agonists.ACS Phys Chem Au. 2025 Jun 6;5(4):367-374. doi: 10.1021/acsphyschemau.5c00008. eCollection 2025 Jul 23. ACS Phys Chem Au. 2025. PMID: 40727226 Free PMC article.
References
-
- Caughey GE; James MJ; Cleland LG Prostaglandins and Leukotrienes. In Encyclopedia of Human Nutrition; Elsevier, 2005; pp 42–49.
-
- Sun Y-P; Oh SF; Uddin J; Yang R; Gotlinger K; Campbell E; Colgan SP; Petasis NA; Serhan CN Resolvin D1 and Its Aspirin-Triggered 17R Epimer. J. Biol. Chem 2007, 282 (13), 9323–9334. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources